Skip to Main Content


Michael P. DiGiovanna, M.D., Ph.D.

Yale Medicine Magazine, 2002 - Autumn


Michael P. DiGiovanna, M.D. ’90, Ph.D. ’90, associate professor of medicine (oncology) and pharmacology and co-director of the Breast Cancer Research Program at the Yale Cancer Center, received a $200,000 grant from the Breast Cancer Research Foundation to investigate the gene HER2, which can be predictive of the prognosis of breast cancer. DiGiovanna was also awarded a four-year grant of almost $1 million to study drugs that target HER2 in connection with anti-estrogen treatments.